Rare and Variant Histologies in Bladder Cancer

At the ESMO Congress 2024, Syed Hussain, MBBS, MSc, MD, FRCP, of the University of Sheffield Medical School, summarizes his presentation on rare and predominant variant histologies in bladder cancer.

Dr. Hussain draws attention to the slow pace of improved outcomes in these histologies because patients are often excluded from clinical trials. He provides a global call to action to increase efforts to move this field forward in the same way urothelial cancer has made strides in the past decade.

View his continued comments on Putting the Spotlight on Rare Bladder Cancers.